Medicon Valley Alliance and Fareva would like to welcome you to a Good Morning Meeting 28th of April 2026. Embarking on the journey from drug discovery to commercialization is fraught with obstacles, from unexpected issues in chemical development to challenges in drug product manufacturing. Not only is developing a new drug expensive, but an extraordinarily […]

Drug development has transformed immeasurably over the past decade. Manufacturing costs have risen, particularly for biologics (incl. CGT) and personalized medicines. In addition, the availability of comparator drug products has become less certain, making traditional packaging approaches not the most suitable for current clinical trial requirements. In response, contract manufacturing organizations (CMOs) are increasingly offering […]

This meeting will present current approaches and technologies in drug discovery within oncology and neuroscience research. The programme brings together perspectives on how different preclinical strategies and model systems support drug development from early discovery through IND. Key aspects of antibody–drug conjugate (ADC) development will be covered, including considerations related to efficacy, safety, and resistance. […]

Medicon Valley Alliance and Arithmos would like to welcome you to a Good Morning Meeting 27th of May 2026. The Trial Master File has always been more than a place to store documents. However for too long it has been treated as exactly that. Your records are quietly telling you something about the health of […]

Regulated bioanalysis continues to evolve alongside increasingly complex therapeutic modalities and the need to accelerate drug development without compromising data quality. Recent years have seen a shift toward more streamlined, fit-for-purpose bioanalytical strategies, prompting a re-evaluation of long-standing conventions while remaining firmly grounded in science. This Good Morning Meeting will highlight current hot topics in […]

The modern discovery lab is no longer defined by geography alone – it is defined by how seamlessly science and execution connect across borders. Today’s most ambitious therapeutic programs – from first-in-class transcriptional degraders in resistant leukemias to rapidly advancing small-molecule or other modalities series – demand both deep biological insight and tightly integrated development […]

Medicon Valley Alliance and Smithers would like to welcome you to a Good Morning Meeting 14th of April 2026. Extractables and leachables remain a critical component of product quality and patient protection across pharmaceutical, biotech, and combination products. This session provides a practical overview of E&L fundamentals, recent regulatory developments, and the evolving expectations shaping […]

Medicon Valley Alliance, in collaboration with Probio, is pleased to invite you to an inspiring morning meeting focusing on next-generation strategies in early-stage therapeutic antibody discovery. The meeting will highlight how functional screening can fundamentally improve lead generation by addressing one of the key bottlenecks in antibody discovery: the low proportion of functional clones among […]

The Technical University of Denmark’s Biotech Lifelong Learning program works closely with companies to develop short, practical training for the life science sector. We see every day how quickly industry roles are changing and how often skills needs outpace the available training. This Good Morning Meeting is a working conversation that brings academia and industry […]

Join us for a fireside chat and an insightful morning that uncovers real stories behind biotech/pharma innovation. From the spark of an idea to developing a drug candidate, we’ll dive into how visionary science becomes reality – through persistence, partnership, and creativity. Hear first-hand accounts on company creation, the hurdles of fundraising, innovative solutions, and […]

Europe’s biotech sector is under intense pressure – from capital scarcity and investor caution to fierce global competition and rising expectations for technical and operational excellence. But with pressure comes opportunity. This event brings together leading experts in biotech, venture capital, partnering, and investment to reveal how European biotech companies can build the capabilities, capital […]

Join us for a morning where biological insight meets therapeutic ambition, and the path from concept to clinic comes into sharp focus. Medicon Valley Alliance and Syngene International would like to welcome you to a Good Morning Meeting 21th of January 2026. Engage with leaders shaping tomorrow’s treatments, and gain perspectives that strengthen scientific collaboration […]

Medicon Valley Alliance and Smithers would like to welcome you to a Good Morning Meeting 26th of November 2025. Design verification of combination pharmaceutical–medical devices is a critical step in ensuring regulatory compliance and product performance. This seminar on parenteral delivery systems explores best practices for developing robust strategies, aligning with regulatory requirements, and testing […]

Medicon Valley Alliance are pleased to invite you to an exclusive Good Morning Meeting hosted by Theradex Oncology and Simsen Diagnostics on 18h of November 2025. Designed specifically for pharmaceutical companies developing cancer therapies, this gathering offers an opportunity to gain actionable insights and explore innovative solutions for oncology clinical trials. Sharing the latest strategies […]

Medicon Valley Alliance and Fios Genomics are pleased to invite you to a Good Morning Meeting on the 28th of October 2025 in Copenhagen. The road to new therapies is long, costly, and full of risk, but smarter use of data can change the odds. This session will explore how bioinformatics can drive success in […]

Medicon Valley Alliance and Capish are pleased to invite you to a Good Morning Meeting on the 22th of October 2025 in Copenhagen. In drug development, data quality is not just a box to tick — it is the backbone of regulatory success and patient safety. Poorly managed data can result in delayed approvals, critical […]

Medicon Valley Alliance and Svar Life Science would like to welcome you to a Good Morning Meeting 21st of October 2025. As regulatory expectations continue to evolve, the demand for potency assays that accurately reflect a drug’s mechanism of action has never been greater. Potency must be tightly controlled, recognized as a critical quality attribute […]

How today’s innovators are tackling difficult cancer targets, refining models, and advancing ethical, effective drug development Learn more about our innovative oncology R&D, integrating scientific expertise with the 3Rs: Replace, Reduce, Refine of animal use in research for ethical responsibility. Featuring ChemPartner’s end-to-end platforms, case studies on KRAS G12C inhibitors and HER2 x TROP2 bispecific […]

Medicon Valley Alliance and Cencora PharmaLex are pleased to invite you to a Good Morning Meeting on the 18th of September 2025 in Copenhagen focusing on regulatory digital initiatives in the EU. Let’s discuss about regulatory digital initiatives in the EU such as ePI, eAF, IRIS and PMS. – Key challenges in pharmaceutical product lifecycle […]

Medicon Valley Alliance and BioAgilytix would like to welcome you to a Good Morning Meeting 9th of September 2025. In recent years, we have seen changes in regulations that affect bioanalytical strategies for drug development. Moving towards using leaner approaches, building in efficiencies, and simplifying overall strategies with the ultimate goal of reducing the time […]

Medicon Valley Alliance and TFS would like to welcome you to a Good Morning Meeting on the 18th of June 2025. Pharmacovigilance (PV) is a dynamic and essential part of ensuring post-marketing safety, especially as regulations evolve and new data types emerge. In this session, we’ll explore the critical steps involved in setting up a […]

Medicon Valley Alliance and Pharmaron would like to welcome you to a Good Morning Meeting 11th of June 2025. Imagine trying to discover and develop a medicine without knowledge of its metabolism and pharmacokinetic properties, or being able to contextualise drug behaviour across species using a range of computational, in vitro and in vivo approaches? […]

Medicon Valley Alliance and Smithers would like to welcome you to a Good Morning Meeting 4th of June 2025. The assessment of extractables and leachables (E&L) on pharmaceutical products, medical devices, delivery systems, and processing equipment have continued to evolve. This aligns with the expanding exposure of polymeric materials to patients, resulting in the path […]

Medicon Valley Alliance and Servier are delighted to invite you to Servier’s 2025 R&D Partnering Day in The Nordics Servier is one of the leading French pharmaceutical companies. We have a long-standing commitment to external collaborations, particularly in oncology, neurology and technology platforms, to bring innovative medicines to patients. With our presence in Denmark through […]

Medicon Valley Alliance and PCI would like to welcome you to a Good Morning Meeting 20th of May 2025. The pharmaceutical industry is undergoing a rapid transformation driven by scientific breakthroughs, evolving regulatory landscapes, and the demand for more targeted, patient-centric therapies. Innovation in the Pharmaceutical World will spotlight key advancements shaping the future of […]

Medicon Valley Alliance and Clario would like to welcome you to a Good Morning Meeting 7th of May 2025. Discover an informative seminar delving into the transformative role of artificial intelligence (AI) in clinical trials: where the industry is currently at, common misconceptions in leveraging AI, proactively tackling the potential for bias and navigating the […]

Medicon Valley Alliance and Potter Clarkson would like to welcome you to a Good Morning Meeting 6th of February 2025. Innovation in digital therapeutics is booming as the possibilities offered by AI, an increased appetite to work across technologies and the growing power of data look set to help this market’s value rocket from $6.5bn […]

Medicon Valley Alliance and Fortrea would like to welcome you to a Good Morning Meeting 6th of November 2024. Join us for an insightful exploration of the evolving clinical research landscape as our expert speakers delve into how digital health, technology, and AI are enhancing clinical development productivity. Gain a deeper understanding of the positive […]

Medicon Valley Alliance and Quotient Science would like to welcome you to a Good Morning Meeting 24th of October 2024. Drug product optimization is a critical development step that is common for most drugs that are progressing through today’s development pipelines to respond to suboptimal exposure profiles, to transition from an early development formulation to […]

Medicon Valley Alliance and Kvantify would like to welcome you to a Good Morning Meeting 26th of September 2024. Our upcoming presentation will explore the transformative role of computational methods in drug discovery, which save time, conserve resources, and enhance efficiency in drug discovery pipelines. We’ll demonstrate how novel physics-based methods, rooted in physical principles, […]